← All trials
NCT06196255
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 25, 2023
- Primary completion
- Jan 1, 2027
- Completion date
- Jan 1, 2028
- First posted
- Jan 9, 2024
- Last posted
- Jan 9, 2024
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Xuzhou Medical UniversityLead sponsor
- Xuzhou Medical UniversitySponsor investigator
- Xuzhou Medical UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.